Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedFeb 21, 2026
DataAggregated Company Financials
Companies27
  • 7D5.0%
  • 3M13.6%
  • 1Y20.0%
  • YTD2.6%

The Biotech industry is up 5.0% in the last week, with Bright Minds Biosciences up 14%. In the same time, ME Therapeutics Holdings was down 16%. This means that the industry has gained 20% over the past year. Looking forward, earnings are forecast to decline by 2.2% per year.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Feb 2026CA$2.9bCA$93.7m-CA$250,802,084.5121.4x-11.5x30.8x
Mon, 19 Jan 2026CA$2.9bCA$95.8m-CA$244,410,346.4423.2x-11.7x29.8x
Wed, 17 Dec 2025CA$2.4bCA$97.9m-CA$237,465,841.6723.6x-10x24.3x
Fri, 14 Nov 2025CA$2.3bCA$95.2m-CA$229,819,256.8922.4x-9.8x23.8x
Sun, 12 Oct 2025CA$2.2bCA$95.7m-CA$226,375,006.0223.8x-9.5x22.6x
Tue, 09 Sep 2025CA$1.7bCA$95.5m-CA$221,227,909.7027.3x-7.5x17.5x
Thu, 07 Aug 2025CA$1.6bCA$91.2m-CA$216,030,524.7221.7x-7.4x17.4x
Sat, 05 Jul 2025CA$1.6bCA$91.0m-CA$270,281,087.1323.2x-6x17.8x
Mon, 02 Jun 2025CA$1.5bCA$90.7m-CA$304,183,901.9524.4x-4.9x16.4x
Wed, 30 Apr 2025CA$1.4bCA$92.9m-CA$284,620,509.9419.4x-5x15.4x
Fri, 28 Mar 2025CA$1.5bCA$85.7m-CA$299,369,985.2522.6x-5.1x17.7x
Sun, 23 Feb 2025CA$1.6bCA$88.6m-CA$316,340,761.7226x-5.2x18.5x
Tue, 21 Jan 2025CA$1.6bCA$87.5m-CA$317,942,099.1023.9x-4.9x17.8x
Thu, 19 Dec 2024CA$1.5bCA$83.5m-CA$329,702,155.599.6x-4.5x17.6x
Sat, 16 Nov 2024CA$1.3bCA$83.3m-CA$297,297,219.348.4x-4.4x15.7x
Mon, 14 Oct 2024CA$1.1bCA$80.3m-CA$279,648,906.659x-3.9x13.7x
Wed, 11 Sep 2024CA$989.3mCA$80.3m-CA$282,449,295.899.7x-3.5x12.3x
Fri, 09 Aug 2024CA$1.1bCA$76.1m-CA$332,565,985.1010.8x-3.2x14.1x
Sun, 07 Jul 2024CA$1.1bCA$76.1m-CA$334,473,010.0210.3x-3.4x15x
Tue, 04 Jun 2024CA$1.3bCA$76.8m-CA$359,099,302.0311x-3.5x16.3x
Thu, 02 May 2024CA$916.5mCA$78.8m-CA$302,067,618.0912.6x-3x11.6x
Sat, 30 Mar 2024CA$1.1bCA$88.5m-CA$315,945,403.1211.1x-3.6x12.7x
Mon, 26 Feb 2024CA$1.2bCA$93.1m-CA$320,866,772.9912.6x-3.7x12.6x
Wed, 24 Jan 2024CA$3.6bCA$86.3m-CA$516,788,684.006.6x-6.9x41.4x
Fri, 22 Dec 2023CA$3.6bCA$86.2m-CA$522,022,024.006.9x-6.9x41.6x
Sun, 19 Nov 2023CA$3.8bCA$86.7m-CA$545,065,480.005.5x-7x44x
Tue, 17 Oct 2023CA$3.8bCA$88.9m-CA$531,777,608.005.7x-7.2x43.2x
Thu, 14 Sep 2023CA$3.9bCA$87.3m-CA$506,277,536.005.8x-7.8x45.2x
Sat, 12 Aug 2023CA$4.0bCA$85.8m-CA$521,748,945.006.9x-7.6x46.3x
Mon, 10 Jul 2023CA$4.1bCA$81.6m-CA$517,313,568.0013.1x-7.9x50.1x
Wed, 07 Jun 2023CA$3.9bCA$86.5m-CA$553,541,221.0012.6x-7.1x45.3x
Fri, 05 May 2023CA$3.8bCA$82.5m-CA$585,085,399.0011.2x-6.5x46x
Sun, 02 Apr 2023CA$2.4bCA$90.6m-CA$601,991,593.009.8x-4.1x27x
Tue, 28 Feb 2023CA$2.7bCA$90.4m-CA$590,103,690.008.5x-4.5x29.7x
Price to Earnings Ratio

-4.5x


Total Market Cap: CA$2.7bTotal Earnings: -CA$590,103,690.00Total Revenue: CA$90.4mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -6x202420252026
Current Industry PE
  • Investors are optimistic on the Canadian Biotechs industry, and appear confident in long term growth rates.
  • The industry's 3-year average PS ratio of 25.3x is exceeded by the industry's current PS ratio of 30.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market1.43%
Healthcare-0.10%
Biotech5.02%
Biotech5.02%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DRUG Bright Minds BiosciencesCA$118.0214.0%
+CA$142.1m		130.7%PB12.9x
EPRX Eupraxia PharmaceuticalsCA$11.681.7%
+CA$107.1m		121.2%PB8.6x
EDT Spectral MedicalCA$1.353.8%
+CA$14.6m		107.7%PS146x
HBP Helix BioPharmaCA$2.008.1%
+CA$11.5m		104.1%PB9.5x
MDNA Medicenna TherapeuticsCA$0.908.4%
+CA$5.8m		-21.7%PB12.1x

Latest News

CYTO
CA$0.10
Cytophage Technologies
7D
-39.4%
1Y
-59.2%
EPRX
CA$11.68
Eupraxia Pharmaceuticals
7D
1.7%
1Y
121.2%
MDNA
CA$0.90
Medicenna Therapeutics
7D
8.4%
1Y
-21.7%
MSCL
CA$15.59
Satellos Bioscience
7D
-1.0%
1Y
66.6%
HEAL
CA$0.10
Restart Life Sciences
7D
-23.1%
1Y
-9.1%
SVA
CA$0.14
Sernova Biotherapeutics
7D
-3.4%
1Y
-30.0%
SHRX
CA$2.25
Sharp Therapeutics
7D
2.3%
1Y
2.3%
METX
CA$2.50
ME Therapeutics Holdings
7D
-16.4%
1Y
n/a
EDT
CA$1.35
Spectral Medical
7D
3.8%
1Y
107.7%
DRUG
CA$118.02
Bright Minds Biosciences
7D
14.0%
1Y
130.7%
HEM
CA$0.085
Hemostemix
7D
-5.6%
1Y
-51.4%
DTC
CA$0.65
Defence Therapeutics
7D
4.8%
1Y
-52.9%
ATLE
CA$0.15
Atlas Energy
7D
-6.1%
1Y
-22.5%
MRVL
CA$0.12
Marvel Biosciences
7D
-20.0%
1Y
-20.0%
HBP
CA$2.00
Helix BioPharma
7D
8.1%
1Y
104.1%
RVX
CA$0.11
Resverlogix
7D
15.8%
1Y
144.4%